Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 119
Inquire Before Buying

Notes:

Production, means the output of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

- Verva Pharmaceuticals

- Zafgen

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report 2016

Table of Contents
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report 2016
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Segment by Type
1.2.1 Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Segment by Application
1.3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2011-2021)
2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competitive Situation and Trends
2.5.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Concentration Rate
2.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue (Value) by Region (2011-2016)
3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Region (2011-2016)
3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Regions (2011-2016)
4.2 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type (2011-2016)
5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2011-2016)
5.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2011-2016)
6 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Application
6.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Profiles/Analysis
7.1 Conatus Pharmaceuticals
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Daewoong Pharmaceutical
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Galmed International
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Kyorin Pharmaceutical
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Metabolic Solutions Development
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Novartis AG
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Phenex Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Raptor Pharmaceuticals
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 TCM Biotech International
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Tobira Therapeutics
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Verva Pharmaceuticals
7.12 Zafgen
8 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
8.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2016-2021)
12.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue Forecast (2016-2021)
12.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2016-2021)
12.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2016-2021)
12.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production of Key Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 Manufacturers
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 5 Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Regions (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Regions (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Market Share by Regions
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Market Share by Regions
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market by Regions (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Regions
Table North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Import & Export (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Type (2011-2016)
Figure Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure 2015 Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application (2011-2016)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2011-2016)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Galmed International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table TCM Biotech International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Tobira Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Regions (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Regions (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2016-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2016-2021)
  • China Pet Nutrition Cream Market Research Report 2017
    Published: 22-Mar-2017        Price: US 3200 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Pet Nutrition Cream Revenue, means the sales value of Pet Nutrition Cream This report studies Pet Nutrition Cream in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - CHZK - Nourse - RedDog - Gimcat - Vitscan - BOTH - GIMPET - IN-PLUS - GOLDEN - G-PET ......
  • China Hairball Solution Market Research Report 2017
    Published: 22-Mar-2017        Price: US 3200 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Hairball Solution Revenue, means the sales value of Hairball Solution This report studies Hairball Solution in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - CHZK - Nourse - RedDog - Gimcat - Vitscan - BOTH - GIMPET - IN-PLUS - GOLDEN - G-PET ......
  • EMEA (Europe, Middle East and Africa) Prednisolone Acetate Market Report 2017
    Published: 22-Mar-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the EMEA Prednisolone Acetate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (volume), revenue (value), market share and growth rate of Prednisolone Acetate for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • EMEA (Europe, Middle East and Africa) Porcine Serum Market Report 2017
    Published: 22-Mar-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the EMEA Porcine Serum market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (volume), revenue (value), market share and growth rate of Porcine Serum for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle Ea......
  • EMEA (Europe, Middle East and Africa) Histone Deacetylase (HDAC) Inhibitors Market Report 2017
    Published: 22-Mar-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the EMEA Histone Deacetylase (HDAC) Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (volume), revenue (value), market share and growth rate of Histone Deacetylase (HDAC) Inhibitors for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, U......
  • EMEA (Europe, Middle East and Africa) Erbitux Market Report 2017
    Published: 22-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the EMEA Erbitux market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (volume), revenue (value), market share and growth rate of Erbitux for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East: Saudi Ar......
  • United States Pet Vaccine Market Report 2017
    Published: 22-Mar-2017        Price: US 3800 Onwards        Pages: 96
    In this report, the United States Pet Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Pet ......
  • United States Erdosteine Market Report 2017
    Published: 22-Mar-2017        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Erdosteine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Erdos......
  • United States Insulin Glargine Market Report 2017
    Published: 22-Mar-2017        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Insulin Glargine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs